| scholarly article | Q13442814 |
| P50 | author | Elizabeth Ann L Enninga | Q86260604 |
| Wendy K. Nevala | Q112876043 | ||
| P2093 | author name string | Svetomir N Markovic | |
| Shernan G Holtan | |||
| P2860 | cites work | Noninvasive prenatal diagnosis: past, present, and future | Q37656046 |
| Improving cancer immunotherapy by targeting tumor-induced immune suppression | Q37830362 | ||
| Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma | Q38327993 | ||
| Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells. | Q38333437 | ||
| Quantification of free circulating DNA as a diagnostic marker in lung cancer | Q38350044 | ||
| Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia | Q39296306 | ||
| TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia | Q39356539 | ||
| Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer | Q39576387 | ||
| TLR3 deficiency in patients with herpes simplex encephalitis | Q40080041 | ||
| Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma | Q40327246 | ||
| Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. | Q40860477 | ||
| Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells | Q41088207 | ||
| Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma | Q41611886 | ||
| Th1-type immunity is incompatible with successful pregnancy | Q41632972 | ||
| Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system | Q42477516 | ||
| Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism | Q43073795 | ||
| DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. | Q43540280 | ||
| NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. | Q43562662 | ||
| Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells | Q43582877 | ||
| Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability | Q43640076 | ||
| Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by nuclear factor-kappaB. | Q43667452 | ||
| Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. | Q44079689 | ||
| Incidence and prognostic value of multiple gene promoter methylations in gliomas | Q44664373 | ||
| The history of Toll-like receptors - redefining innate immunity. | Q46240771 | ||
| Differences in the expression of TLRs and inflammatory cytokines in pre-eclamptic compared with healthy pregnant women | Q46313900 | ||
| Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer | Q46748260 | ||
| Effects of preanalytical factors on the molecular size of cell-free DNA in blood | Q47391984 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. | Q47889241 | ||
| Coley's toxins in perspective | Q48973854 | ||
| Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial. | Q50904556 | ||
| Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. | Q51047134 | ||
| Epitope landscape in breast and colorectal cancer. | Q51894674 | ||
| Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. | Q21092390 | ||
| Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 | ||
| Folding DNA to create nanoscale shapes and patterns | Q22122462 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection | Q24561706 | ||
| An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
| A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening | Q24564781 | ||
| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes | Q24676216 | ||
| A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas | Q24679739 | ||
| Immunology of term and preterm labor | Q24801342 | ||
| Chimeric antigen receptor therapy for cancer | Q27013599 | ||
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Nivolumab plus ipilimumab in advanced melanoma | Q27852310 | ||
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | Q27860650 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 | ||
| Cancer-related inflammation | Q27860907 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| Immune checkpoint blockade: a common denominator approach to cancer therapy | Q28083981 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Antibody therapy of cancer | Q28262538 | ||
| The epigenomics of cancer | Q28289975 | ||
| Alterations at the rel locus in human lymphoma | Q28299388 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Analysis of circulating tumor DNA to monitor metastatic breast cancer | Q29614797 | ||
| Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
| Chimeric antigen receptor T cells for sustained remissions in leukemia | Q29617588 | ||
| Rudolf Virchow and modern aspects of tumor pathology. | Q52398106 | ||
| Synthesis of T helper 2-type cytokines at the maternal-fetal interface. | Q52885481 | ||
| Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. | Q52968193 | ||
| Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy. | Q54185144 | ||
| PD-L1 expression on tolerogenic APCs is controlled by STAT-3. | Q54617418 | ||
| Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. | Q54753744 | ||
| Free DNA in the serum of cancer patients and the effect of therapy. | Q55492005 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Gene promoter hypermethylation in tumors and serum of head and neck cancer patients | Q57240069 | ||
| Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse | Q58211903 | ||
| Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia | Q58825399 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| First-trimester maternal plasma cell-free fetal DNA and preeclampsia | Q61826541 | ||
| Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer | Q67866197 | ||
| REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma | Q70863351 | ||
| Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder | Q72531477 | ||
| Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease | Q72694781 | ||
| Presence of fetal RNA in maternal plasma | Q73162878 | ||
| TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas | Q73409861 | ||
| Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 | Q73540287 | ||
| Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients | Q74020294 | ||
| Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12 | Q74602340 | ||
| Immunopathology of the implantation site utilizing monoclonal antibodies to natural killer cells in women with recurrent pregnancy losses | Q74655086 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process | Q78598234 | ||
| Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma | Q79441673 | ||
| ??? | Q94720111 | ||
| Elevated level of cell-free plasma DNA is associated with breast cancer | Q80152253 | ||
| Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15 | Q80489712 | ||
| Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study | Q83575998 | ||
| An organ system based approach to prognosis in advanced melanoma | Q84264266 | ||
| Rethinking clinical delivery of adult stem cell therapies | Q87507566 | ||
| Cell-free fetal DNA--a trigger for parturition | Q88151873 | ||
| Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Chronic inflammation and cytokines in the tumor microenvironment | Q33678275 | ||
| Epidemiology of primary liver cancer | Q33750533 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Detection and quantification of mutations in the plasma of patients with colorectal tumors | Q34132363 | ||
| Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. | Q34139666 | ||
| Circulating DNA in plasma or serum. | Q34144929 | ||
| Human molecular embryogenesis: an overview | Q34300779 | ||
| CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
| Fetal DNA in maternal plasma: emerging clinical applications | Q34351279 | ||
| T cell-dependent B cell activation | Q34363600 | ||
| The Th1/Th2 paradigm | Q34429440 | ||
| IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma | Q34440364 | ||
| Tissue biomarkers in melanoma patients treated with TIL | Q34531444 | ||
| Macrophages regulate the angiogenic switch in a mouse model of breast cancer | Q34582812 | ||
| Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases | Q34627305 | ||
| Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma | Q34855293 | ||
| Akonni TruTip(®) and Qiagen(®) methods for extraction of fetal circulating DNA--evaluation by real-time and digital PCR. | Q34927319 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. | Q35050165 | ||
| Chronic inflammation and immunologic-based constraints in malignant disease | Q35575974 | ||
| Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma | Q35604043 | ||
| A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI | Q36205202 | ||
| Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction | Q36228832 | ||
| Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts | Q36636006 | ||
| Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer | Q36663615 | ||
| TLR agonists: our best frenemy in cancer immunotherapy | Q36850457 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma | Q37375286 | ||
| NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma | Q37377834 | ||
| Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents | Q37406706 | ||
| TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination | Q37461812 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 424 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics | |
| P478 | volume | 6 |
| Q50356518 | Cell-free fetal DNA and spontaneous preterm birth |
| Q37593852 | Circulating nucleic acids: An analysis of their occurrence in malignancies. |
| Q51067523 | Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface. |
| Q91591027 | Inflammation-mediated generation and inflammatory potential of human placental cell-free fetal DNA |
Search more.